Share Twitter LinkedIn Facebook Email Elizabeth Swisher, MD of UW Medicine @UWMedicine discusses characterization of patients with long-term responses to rucaparib in recurrent ovarian cancer. Read here:Â https://meetinglibrary.asco.org/record/185449/abstract
OVHIPEC-1 Phase 3 Trial: Cytoreductive Surgery in Advanced Ovarian Cancer Lot Aronson, MD Ovarian 3 Mins Read
FDA Grants Full Approval for Mirvetuximab Soravtansine-gynx (Elahere) for FRα positive, platinum-resistant epithelial ovarian with Robert Coleman, MD Ovarian 4 Mins Read